1. Home
  2. AIRI vs FEMY Comparison

AIRI vs FEMY Comparison

Compare AIRI & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Air Industries Group

AIRI

Air Industries Group

N/A

Current Price

$2.65

Market Cap

12.3M

Sector

Industrials

ML Signal

N/A

Logo Femasys Inc.

FEMY

Femasys Inc.

N/A

Current Price

$1.42

Market Cap

11.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AIRI
FEMY
Founded
1979
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.3M
11.5M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
AIRI
FEMY
Price
$2.65
$1.42
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $16.50
AVG Volume (30 Days)
34.4K
★ 103.5K
Earning Date
11-09-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
24.39
★ 44.71
EPS
★ N/A
N/A
Revenue
★ $47,921,000.00
$2,293,313.00
Revenue This Year
$4.34
N/A
Revenue Next Year
N/A
$328.45
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 40.77
52 Week Low
$2.30
$0.29
52 Week High
$3.95
$6.29

Technical Indicators

Market Signals
Indicator
AIRI
FEMY
Relative Strength Index (RSI) 48.14 40.27
Support Level $2.50 $1.26
Resistance Level $2.75 $3.21
Average True Range (ATR) 0.23 0.13
MACD 0.02 0.04
Stochastic Oscillator 50.53 62.71

Price Performance

Historical Comparison
AIRI
FEMY

About AIRI Air Industries Group

Air Industries Group is an aerospace and defense company. Its manufacturers of precision components and assemblies for large aerospace and defense prime contractors. The company products include landing gears, flight controls, engine mounts and components for aircraft jet engines, ground turbines and other complex machines. The ultimate end-user of products is the U.S. Government, international governments, and commercial global airlines.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: